great find - one would expect that it should be CX Bladder. Given that Kaiser have approved the commercial use, one would expect that the LCD must not be too far away. Could be a very good week for the share price.
- Forums
- ASX - By Stock
- PEB
- LCD Meeting next week to consider "Prognostic and Predictive Molecular Classifier for Bladder Cancer"
LCD Meeting next week to consider "Prognostic and Predictive Molecular Classifier for Bladder Cancer", page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEB (NZSX) to my watchlist
(20min delay)
|
|||||
Last
15.8¢ |
Change
0.003(1.94%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
15.6¢ | 16.4¢ | 15.6¢ | $35.83K | 223.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 12879 | 15.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.4¢ | 76943 | 0 |
Last trade - 11.00am 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
PEB (NZSX) Chart |